Hyphens Pharma International Ltd. (SG:1J5) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hyphens Pharma International Ltd. reported a 22.1% increase in revenue for the first nine months of 2024, reaching S$143.5 million, driven by strong sales in Singapore and Malaysia. Despite a 12.1% rise in gross profit for the third quarter, net profit after tax slightly declined due to increased distribution and administrative costs. The company remains optimistic about its financial growth, bolstered by favorable currency exchange rates.
For further insights into SG:1J5 stock, check out TipRanks’ Stock Analysis page.